Cargando…

Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis

Studies on elevated fasting insulin or insulin resistance (IR) and cardiovascular or all-cause mortality risk in non-diabetic individuals have yielded conflicting results. This meta-analysis aimed to evaluate the association of elevated fasting insulin levels or IR as defined by homeostasis model as...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaohong, Li, Jun, Zheng, Shuiping, Luo, Qiuyun, Zhou, Chunmei, Wang, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448479/
https://www.ncbi.nlm.nih.gov/pubmed/28811358
http://dx.doi.org/10.1042/BSR20170947
_version_ 1783408704029196288
author Zhang, Xiaohong
Li, Jun
Zheng, Shuiping
Luo, Qiuyun
Zhou, Chunmei
Wang, Chaoyang
author_facet Zhang, Xiaohong
Li, Jun
Zheng, Shuiping
Luo, Qiuyun
Zhou, Chunmei
Wang, Chaoyang
author_sort Zhang, Xiaohong
collection PubMed
description Studies on elevated fasting insulin or insulin resistance (IR) and cardiovascular or all-cause mortality risk in non-diabetic individuals have yielded conflicting results. This meta-analysis aimed to evaluate the association of elevated fasting insulin levels or IR as defined by homeostasis model assessment of IR (HOMA-IR) with cardiovascular or all-cause mortality in non-diabetic adults. We searched for relevant studies in PubMed and Emabse databases until November 2016. Only prospective observational studies investigating the association of elevated fasting insulin levels or HOMA-IR with cardiovascular or all-cause mortality risk in non-diabetic adults were included. Risk ratio (RR) with its 95% confidence intervals (CIs) was pooled for the highest compared with the lowest category of fasting insulin levels or HOMA-IR. Seven articles involving 26976 non-diabetic adults were included. The pooled, adjusted RR of all-cause mortality comparing the highest with the lowest category was 1.13 (95% CI: 1.00–1.27; P=0.058) for fasting insulin levels and 1.34 (95% CI: 1.11–1.62; P=0.002) for HOMA-IR, respectively. When comparing the highest with the lowest category, the pooled adjusted RR of cardiovascular mortality was 2.11 (95% CI: 1.01–4.41; P=0.048) for HOMA-IR in two studies and 1.40 (95% CI: 0.49–3.96; P=0.526) for fasting insulin levels in one study. IR as measured by HOMA-IR but not fasting insulin appears to be independently associated with greater risk of cardiovascular or all-cause mortality in non-diabetic adults. However, the association of fasting insulin and HOMA-IR with cardiovascular mortality may be unreliable due to the small number of articles included.
format Online
Article
Text
id pubmed-6448479
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-64484792019-04-16 Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis Zhang, Xiaohong Li, Jun Zheng, Shuiping Luo, Qiuyun Zhou, Chunmei Wang, Chaoyang Biosci Rep Research Articles Studies on elevated fasting insulin or insulin resistance (IR) and cardiovascular or all-cause mortality risk in non-diabetic individuals have yielded conflicting results. This meta-analysis aimed to evaluate the association of elevated fasting insulin levels or IR as defined by homeostasis model assessment of IR (HOMA-IR) with cardiovascular or all-cause mortality in non-diabetic adults. We searched for relevant studies in PubMed and Emabse databases until November 2016. Only prospective observational studies investigating the association of elevated fasting insulin levels or HOMA-IR with cardiovascular or all-cause mortality risk in non-diabetic adults were included. Risk ratio (RR) with its 95% confidence intervals (CIs) was pooled for the highest compared with the lowest category of fasting insulin levels or HOMA-IR. Seven articles involving 26976 non-diabetic adults were included. The pooled, adjusted RR of all-cause mortality comparing the highest with the lowest category was 1.13 (95% CI: 1.00–1.27; P=0.058) for fasting insulin levels and 1.34 (95% CI: 1.11–1.62; P=0.002) for HOMA-IR, respectively. When comparing the highest with the lowest category, the pooled adjusted RR of cardiovascular mortality was 2.11 (95% CI: 1.01–4.41; P=0.048) for HOMA-IR in two studies and 1.40 (95% CI: 0.49–3.96; P=0.526) for fasting insulin levels in one study. IR as measured by HOMA-IR but not fasting insulin appears to be independently associated with greater risk of cardiovascular or all-cause mortality in non-diabetic adults. However, the association of fasting insulin and HOMA-IR with cardiovascular mortality may be unreliable due to the small number of articles included. Portland Press Ltd. 2017-09-07 /pmc/articles/PMC6448479/ /pubmed/28811358 http://dx.doi.org/10.1042/BSR20170947 Text en © 2017 The Author(s). http://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Articles
Zhang, Xiaohong
Li, Jun
Zheng, Shuiping
Luo, Qiuyun
Zhou, Chunmei
Wang, Chaoyang
Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
title Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
title_full Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
title_fullStr Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
title_full_unstemmed Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
title_short Fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
title_sort fasting insulin, insulin resistance, and risk of cardiovascular or all-cause mortality in non-diabetic adults: a meta-analysis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448479/
https://www.ncbi.nlm.nih.gov/pubmed/28811358
http://dx.doi.org/10.1042/BSR20170947
work_keys_str_mv AT zhangxiaohong fastinginsulininsulinresistanceandriskofcardiovascularorallcausemortalityinnondiabeticadultsametaanalysis
AT lijun fastinginsulininsulinresistanceandriskofcardiovascularorallcausemortalityinnondiabeticadultsametaanalysis
AT zhengshuiping fastinginsulininsulinresistanceandriskofcardiovascularorallcausemortalityinnondiabeticadultsametaanalysis
AT luoqiuyun fastinginsulininsulinresistanceandriskofcardiovascularorallcausemortalityinnondiabeticadultsametaanalysis
AT zhouchunmei fastinginsulininsulinresistanceandriskofcardiovascularorallcausemortalityinnondiabeticadultsametaanalysis
AT wangchaoyang fastinginsulininsulinresistanceandriskofcardiovascularorallcausemortalityinnondiabeticadultsametaanalysis